New device may predict kidney recovery in ICU patients
NCT ID NCT02812784
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the Nephrocheck™ device can predict if early acute kidney injury will reverse within 72 hours in patients with septic shock. Researchers enrolled 184 adults in the ICU and measured the device's accuracy. The goal is to help doctors decide who might recover without aggressive treatments like dialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nephrocheck™ device
- What this could lead to
- If successful, this could help doctors quickly identify which patients with septic shock will recover kidney function without needing dialysis.
- What could go wrong
- This is a completed study with 184 participants, so results are available but may not apply to all patients. The device is a diagnostic tool, not a treatment, so it won't directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEADING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Avranches-Granville
Avranches, 50300, France
-
CH Cahors
Cahors, 46000, France
-
CH Dax
Dax, 40100, France
-
CH Marc Jacquet
Melun, 77000, France
-
CH Paris-Saint Joseph
Paris, 75, France
-
CH Salon-de-provence
Salon-de-Provence, 13300, France
-
CH de Mont-de-Marsan
Mont-de-Marsan, 40000, France
-
CHU Amiens
Amiens, 80054, France
-
CHU Montpellier
Montpellier, 34172, France
-
CHU Poitiers
Poitiers, 86000, France
-
CHU Saint-Etienne
Saint-Etienne, 42000, France